Panolos Bioscience

Panolos Bioscience is a biotechnology company focused on the development of treatments for cancer, anti-immune diseases, and rare diseases. It holds the patented αART technology, which enhances the efficacy of mono-specific or multi-specific antibody therapies through the use of VEGF receptor backbones. The company has a unique R&D system and currently owns multiple pipeline products.